Home » Topics » Regulatory

Regulatory
RSS

Pamidronate evaluated as potential therapy for bone cancer

Oct. 9, 1997

Celgene studies chirally pure mexiletine for relief of neuropathic pain

Oct. 9, 1997

Mylan receives FDA approval for generic verapamil

Oct. 9, 1997

Geref cleared for pediatric growth disorders in U.S.

Oct. 8, 1997

First approval for Infergen

Oct. 8, 1997

Knoll receives FDA approval for Vicoprofen

Oct. 7, 1997

NTZ: a potential new anti-H. pylori agent

Oct. 7, 1997

HMR and Andrx agree to stipulation in Cardizem CD patent lawsuit

Oct. 7, 1997

Nasonex Nasal Spray cleared for marketing in U.S.

Oct. 6, 1997

FDA clears Serevent Diskus

Oct. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...